Bone marrow-derived progenitor cells in cérébral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

Stroke

Volumn 41, Issue 2, 2010, Pages 218-223

  Pescini, Francesca ^a   Cesari, Francesca ^a   Giusti, Betti ^a   Sarti, Cristina ^a   Zicari, Enza ^b   Bianchi, Silvia ^b   Dotti, Maria T ^b   Federico, Antonio ^b   Balestrino, Maurizio ^c   Enrico, Adriano ^c   Gandolfo, Carlo ^c   Gori, Anna M ^a,d   Abbate, Rosanna ^a   Pantoni, Leonardo ^a   Inzitari, Domenico ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Don Carlo Gnocchi IRCCS Foundation   (Italy)

Author keywords

CADASIL; Endothelial dysfunction; Phenotype; Progenitor cells; Small vessel

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASCULOTROPIN RECEPTOR 2; BIOLOGICAL MARKER; MEMBRANE ANTIGEN;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; B LYMPHOCYTE; CADASIL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MOTOR PERFORMANCE; PHENOTYPE; PRIORITY JOURNAL; REVASCULARIZATION; STEM CELL; STROKE; BONE MARROW CELL; BRAIN ARTERY; CELL COUNT; CYTOLOGY; DOWN REGULATION; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; BONE MARROW CELLS; CADASIL; CELL COUNT; CEREBRAL ARTERIES; DEMENTIA; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; STEM CELLS; STROKE;

EID: 77449134478     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.563726     Document Type: Article

References (45)

1. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. Notch 3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707-710.
2. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssière C, Cruaud C, Maciazek J, Weissenbach J, Bousser MG, Bach JF, Tournier-Lasserve E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511-1515.
3. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. CADASIL. Lancet Neurol. 2009;8:643-653.
4. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004;127:2533-2539.
5. Pescini F, Bianchi S, Salvadori E, Poggesi A, Dotti MT, Federico A, Inzitari D, Pantoni L. A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient. J Neurol Sci. 2008;267:170-173.
6. Pescini F, Bianchi S, Dotti MT, Federico A, Inzitari D, Pantoni L. First report of a Romanian CADASIL patient following immigration to Italy. Eur J Neurol. 2007;14:7-8.
7. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain. 2004;127:2031-2038.
8. Viswanathan A, Guichard JP, Gschwendtner A, Buffon F, Cumurcuic R, Boutron C, Vicaut E, Holtmannspötter M, Pachai C, Bousser MG, Dichgans M, Chabriat H. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain. 2006;129:2375-2383.
9. Chabriat H, Pappata S, Ostergaard L, Clark CA, Pachot-Clouard M, Vahedi K, Jobert A, Le Bihan D, Bousser MG. cérébral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke. 2000;31:1904-1912.
10. van den Boom R, Lesnik Oberstein SA, Spilt A, Behloul F, Ferrari MD, Haan J, Westendorp RG, van Buchem MA. cérébral hemodynamics and white matter hyperintensities in CADASIL. J Cereb Blood Flow Metab. 2003;23:599-604.
11. Pfefferkorn T, von Stuckrad-Barre S, Herzog J, Gasser T, Hamann GF, Dichgans M. Reduced cerebrovascular CO(2) reactivity in CADASIL: A transcranial Doppler sonography study. Stroke. 2001;32:17-21.
12. Singhal S, Markus HS. Cerebrovascular reactivity and dynamic autoreg-ulation in nondemented patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencepha-lopathy). J Neurol. 2005;252:163-167.
13. Gobron C, Vahedi K, Vicaut E, Stucker O, Laemmel E, Baudry N, Bousser MG, Chabriat H. Characteristic features of in vivo skin micro-vascular reactivity in CADASIL. J Cereb Blood Flow Metab. 2007;27: 250-257.
14. Peters N, Freilinger T, Opherk C, Pfefferkorn T, Dichgans M. Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL. J Neurol. 2008;255:1203-1208.
15. Stenborg A, Kalimo H, Viitanen M, Terent A, Lind L. Impaired endo-thelial function of forearm resistance arteries in CADASIL patients. Stroke. 2007;38:2692-2697.
16. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularisation. J Clin Invest. 1999;103: 1231-1236.
17. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999-1007. (Pubitemid 41262334)
18. Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O'Rourke F, Nasser AM, Schwindt B, Todd K. Endothelial progenitor cells during cerebrovascular disease. Stroke. 2005;36:151-153.
19. Sobrino T, Hurtado O, Moro MA, Rodríguez-Yáñez M, Castellanos M, Brea D, Moldes O, Blanco M, Arenillas JF, Leira R, Dávalos A, Lizasoain I, Castillo J. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke. 2007;38:2759-2764.
20. Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA, Chang HW. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke. 2008;39: 69-74.
21. Beck H, Voswinckel R, Wagner S, Ziegelhoeffer T, Heil M, Helisch A, Schaper W, Acker T, Hatzopoulos AK, Plate KH. Participation of bone marrow-derived cells in long-term repair processes after experimental stroke. J Cereb Blood Flow Metab. 2003;23:709-717.
22. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, Todo K, Mori K, Stern DM, Soma T, Naritomi H. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation. 2004;109:2972-2975.
23. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state.' A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
24. Gelinàs I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther. 1999;53:471-481.
25. Madureira S, Verdelho A, Ferro J, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Pantoni L, Salvadori E, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D; LADIS Study Group. Development of a neuropsychological battery for the Leu-koaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data. Neuroepidemiology. 2006;27:101-116.
26. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988; 24:709-711.
27. Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Hennerici MG; LADIS Study Group. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology. 2008;70:935-942.
28. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The National High Blood Pressure Education Program Coordinating Committee Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252
29. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:5-20.
30. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
31. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatry Association; 1994: 133.
32. Cesari F, Caporale R, Marcucci R, Caciolli S, Stefano PL, Capalbo A, Macchi C, Vannucci M, Gensini GF, Abbate R, Gori AM. NT-proBNP and the anti-inflammatory cytokines are correlated with endothelial progenitor cells' response to cardiac surgery. Atherosclerosis. 2008;199: 138-146.
33. Nencini P, Sarti C, Innocenti R, Pracucci G, Inzitari D. Acute inflammatory events and ischemic stroke subtypes. Cerebrovasc Dis. 2003;15: 215-221.
34. Cesari F, Sofi F, Caporale R, Capalbo A, Marcucci R, Macchi C, Lova RM, Cellai T, Vannucci M, Gensini GF, Abbate R, Gori AM. Relationship between exercise capacity, endothelial progenitor cells and cyto-chemokines in patients undergoing cardiac rehabilitation. Thromb Haemost. 2009;101:521-526.
35. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hema-tother. 1996;5:213-226.
36. Ruchoux MM, Maurage CA. Endothelial changes in muscle and skin biopsies in patients with CADASIL. Neuropathol Appl Neurobiol. 1998; 24:60-65.
37. Rufa A, Blardi P, De Lalla A, Cevenini G, De Stefano N, Zicari E, Auteri A, Federico A, Dotti MT. Plasma levels of asymmetric dimethylarginine in cérébral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy. Cerebrovasc Dis. 2008;26:636-640.
38. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science. 2000;290: 1775-1779.
39. Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA. 1997;94:4080-4085.
40. Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol. 2002;174:11-20.
41. Zhang ZG, Zhang L, Jiang Q, Chopp M. Bone marrow-derived endothelial progenitor cells participate in cérébral neovascularization after focal cérébral ischemia in the adult mouse. Circ Res. 2002;90:284-288.
42. + cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood. 2001;97:3075-3085.
43. Yoshihara T, Taguchi A, Matsuyama T, Shimizu Y, Kikuchi-Taura A, Soma T, Stern DM, Yoshikawa H, Kasahara Y, Moriwaki H, Nagatsuka K, Naritomi H. Increase in circulating CD34-positive cells in patients with angiographic evidence of moyamoya-like vessels. J Cereb Blood Flow Metab. 2008;28:1086-1089.
44. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T; Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360: 427-435.
45. Jung KH, Roh JK. Circulating endothelial progenitor cells in cerebrovascular disease. J Clin Neurol. 2008;4:139-147.